Bicycle Therapeutics Appoints Stephen J. Hoffman, M.D., Ph.D., As Board Chairman

CAMBRIDGE, Mass. & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptides (Bicycles®) platform, announced today the appointment of Stephen J. Hoffman, M.D., Ph.D., as Chairman of the Board of Directors.

Back to news